Pierre Fabre
Centre d'Immunologie Pierre FABRE
5, avenue Napolean III - BP 497
St. Julien en Genevois Cedex
74164
France
Tel: 33-4-50-35-35-55
Fax: 33-4-50-35-35-90
Website: http://www.cipf.com/
60 articles about Pierre Fabre
-
Pierre Fabre Laboratories Acquires Vertical Bio and its Innovative Targeted Therapy Candidate for Patients Suffering From Non-Small Cell Lung Cancer With MET Alteration
9/12/2023
Pierre Fabre Laboratories , the French pharmaceutical and dermo-cosmetic company, announced the acquisition of Vertical Bio AG, a developer of novel cancer therapies.
-
Pierre Fabre and the EspeRare Foundation start the EDELIFE clinical trial of a prenatal treatment for a rare genetic disease, XLHED
11/15/2021
The EspeRare Foundation and the Pierre Fabre group announced today the start of the EDELIFE clinical trial aimed at confirming the safety and efficacy of ER004, a prenatal treatment for XLHED (X-linked Hypohidrotic Ectodermal Dysplasia), a rare and debilitating congenital disease.
-
Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration With Pierre Fabre
10/7/2021
Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration With Pierre Fabre
-
Atara Biotherapeutics and Pierre Fabre Enter Strategic Collaboration to Commercialize Tabelecleucel (Tab-cel®)
10/4/2021
Atara Biotherapeutics and Pierre Fabre Enter Strategic Collaboration to Commercialize Tabelecleucel (Tab-cel ® )
-
Puma Biotechnology and Pierre Fabre Enter into Exclusive License Agreement to Develop and Commercialize NERLYNX® (neratinib) in Europe
4/1/2019
Pierre Fabre will have exclusive commercialization rights for NERLYNX in European countries excluding Russia and Ukraine, along with countries in North Africa and francophone countries of West Africa.
-
BioSpace takes a quick look at some of the news coming from biotech and pharma companies from across Europe and Asia.
-
For many people France may is synonymous with wines, cheese and rich meals. But the country also has a strong biotech community that how grown significantly over the past decade, with a strong focus on developing clinical drug assets.
-
Pierre Fabre Adopts Veeva OpenData to Enhance Commercial Execution
11/29/2018
Veeva OpenData will provide field teams across 22 countries with accurate customer reference data for better HCP engagement
-
Boston Pharma went on a buying binge, licensing a slew of compounds from GlaxoSmithKline and Novartis in two separate deals.
-
Array BioPharma, Inc. secured approval for its combination treatment for BRAF-mutant metastatic melanoma.
-
Pierre Fabre and Roche extend collaboration agreement on companion diagnostic development
5/20/2018
Pierre Fabre announced today the extension of a collaboration agreement with Roche on companion diagnostic development for W0101.
-
IQVIA and Pierre Fabre Pharmaceuticals Expand Relationship to Deploy IQVIA’s Orchestrated Customer Engagement
12/13/2017
Under the terms of this seven-year agreement, Pierre Fabre Pharmaceuticals will migrate all of its current CRM users to OCE, which Pierre Fabre Pharmaceuticals selected because of its strong “platform of platforms” foundation and open architecture.
-
Cellectar Biosciences And Pierre Fabre Extend Collaboration For Development Of New Phospholipid Drug Conjugates
10/10/2017
-
Pierre Fabre Release: EMA To Start The Review Of The Marketing Authorization Applications For Encorafenib And Binimetinib For The Treatment Of BRAF-Mutant Advanced Melanoma
8/28/2017
-
Noventure And Pierre Fabre Enter Into An Agreement To Commercialise Aprotecol In Italy
7/18/2017
-
Pierre Fabre Acquires Promising Assets From Igenica, Inc. In The Field Of Immuno-Oncology
5/24/2017
-
Pierre Fabre Publishes New Data On Dosing Errors With Generic Propranolol For The Treatment Of Infantile Hemangiomas
4/24/2017
-
Pierre Fabre And H-Immune Announce Strategic Research Partnership To Develop Potentially Ground-Breaking Cancer Immunotherapies
3/21/2017
-
Pierre Fabre And Hill Dermaceuticals Announce A Strategic Commercial Partnership For TOLAK (Fluorouracil) Cream 4% In The USA And Beyond
3/6/2017
-
PIQUR Release: Pharma And Pierre Fabre Announce Partnership In Dermato-Oncology
1/11/2017